Search

Your search keyword '"Tseng, Chia-Cheng"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Tseng, Chia-Cheng" Remove constraint Author: "Tseng, Chia-Cheng" Database Unpaywall Remove constraint Database: Unpaywall
39 results on '"Tseng, Chia-Cheng"'

Search Results

1. Survival outcomes of east Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR tyrosine kinase inhibitors: A network meta‐analysis of real‐world evidence

2. BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters

3. Next generation sequencing reveals miR-431–3p/miR-1303 as immune-regulating microRNAs for active tuberculosis

4. Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study

8. Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation

10. Aberrant DNA methylation of the toll-like receptors 2 and 6 genes in patients with obstructive sleep apnea

14. Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor–tyrosine kinase inhibitors

15. PUB001 Advanced NSCLC Patients at the Extremes of Age in the Era of EGFR-TKIs

16. A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases

17. Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors

18. Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors

19. Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention

20. The impact of clinical parameters on progression-free survival of non-small cell lung cancer patients harboring EGFR-mutations receiving first-line EGFR-tyrosine kinase inhibitors

21. Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

22. Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

24. Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

27. Circulating Endothelial-Derived Activated Microparticle: A Useful Biomarker for Predicting One-Year Mortality in Patients with Advanced Non-Small Cell Lung Cancer

29. Levels of Circulating Microparticles in Lung Cancer Patients and Possible Prognostic Value

Catalog

Books, media, physical & digital resources